Physician profile
Tonya D Lindsell
NPI 1205800133
$30,484.55
in general payments reported to CMS, 2019-2025
21 companies · $11K in 2025
The $11K reported for 2025 was more than what 98% of Corneal and Contact Management providers received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,055 · 2020: $556 · 2021: $1,322 · 2022: $5,394 · 2023: $7,732 · 2024: $2,957 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,575 · Food and Beverage: $8,782 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,800 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,574.69 |
| Food and Beverage | $8,781.53 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,800.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $13,421.57 | 2019-2025 | Cvi Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $5,514.03 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $4,992.59 | 2022-2025 | Infuse, Miebo, Xiidra |
| Alcon Vision LLC | $3,462.99 | 2019-2025 | Dailies Total1, Precision 1, Dailies Aqua Comfort Plus |
| Harrow Eye, LLC | $513.59 | 2025 | Vevye |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $479.60 | 2019-2021 | |
| Oyster Point Pharma, INC. | $337.76 | 2022-2025 | Tyrvaya, Ryzumvi |
| Biotissue Holdings INC. | $301.43 | 2022-2024 | |
| Abb Con-Cise Optical Group LLC | $210.73 | 2019-2024 | Spectacle Lenses, Contact Lens |
| Tarsus Pharmaceuticals, INC. | $176.27 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $159.21 | 2022 | |
| Glaukos Corporation | $149.88 | 2023 | |
| Kala Pharmaceuticals, INC. | $141.86 | 2021-2022 | |
| Apellis Pharmaceuticals, INC. | $124.05 | 2024 | |
| Dompe US, INC. | $107.00 | 2025 | Oxervate |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synergeyes, INC. | $94.75 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $77.99 | 2021 | |
| Optos, INC. | $75.43 | 2019-2021 | |
| Visioneering Technologies, INC. | $64.49 | 2022 | |
| Allergan, INC. | $58.80 | 2021 | |
| Abbvie INC. | $20.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tonya Lindsell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.